Key Points
- Gregg Williams bought 1,737,764 shares on Nov. 15 at an average $1.14 per share (~$1.98M), bringing his total stake to 23,088,579 shares valued at about $26.32M — a reported 8.14% increase in his ownership.
- Williams has been repeatedly accumulating Vivani shares in recent months (e.g., 3,703,703 on Oct. 27 at $1.62 and 2,068,453 on Sept. 15 at $1.16), while the stock trades near $1.47 with a market cap of roughly $93M and an average analyst rating of "Hold" with a $4 consensus target.
Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,737,764 shares of the stock in a transaction dated Saturday, November 15th. The shares were purchased at an average price of $1.14 per share, with a total value of $1,981,050.96. Following the completion of the transaction, the director owned 23,088,579 shares of the company's stock, valued at approximately $26,320,980.06. This trade represents a 8.14% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Gregg Williams also recently made the following trade(s):
- On Monday, October 27th, Gregg Williams acquired 3,703,703 shares of Vivani Medical stock. The stock was purchased at an average price of $1.62 per share, for a total transaction of $5,999,998.86.
- On Wednesday, October 15th, Gregg Williams bought 1,737,764 shares of Vivani Medical stock. The shares were purchased at an average cost of $1.14 per share, for a total transaction of $1,981,050.96.
- On Monday, September 15th, Gregg Williams bought 2,068,453 shares of Vivani Medical stock. The shares were purchased at an average price of $1.16 per share, with a total value of $2,399,405.48.
Vivani Medical Price Performance
NASDAQ VANI opened at $1.47 on Tuesday. The company has a market cap of $92.98 million, a P/E ratio of -3.27 and a beta of 3.15. The stock has a 50-day moving average of $1.47 and a two-hundred day moving average of $1.33. Vivani Medical, Inc. has a 1-year low of $0.91 and a 1-year high of $1.92.
Vivani Medical (NASDAQ:VANI - Get Free Report) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.01. On average, analysts anticipate that Vivani Medical, Inc. will post -0.41 EPS for the current fiscal year.
Analyst Ratings Changes
Several analysts have recently issued reports on the company. Zacks Research upgraded Vivani Medical from a "strong sell" rating to a "hold" rating in a research note on Wednesday, November 12th. Weiss Ratings restated a "sell (d-)" rating on shares of Vivani Medical in a report on Tuesday, October 14th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $4.00 price target on shares of Vivani Medical in a research report on Tuesday, September 2nd. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $4.00.
View Our Latest Stock Report on VANI
Hedge Funds Weigh In On Vivani Medical
A number of institutional investors and hedge funds have recently modified their holdings of VANI. Susquehanna International Group LLP increased its holdings in Vivani Medical by 100.5% in the third quarter. Susquehanna International Group LLP now owns 32,314 shares of the company's stock valued at $46,000 after buying an additional 16,200 shares during the last quarter. Citadel Advisors LLC acquired a new position in shares of Vivani Medical during the 3rd quarter worth about $26,000. Panagora Asset Management Inc. purchased a new position in shares of Vivani Medical in the 2nd quarter valued at about $25,000. Wealthedge Investment Advisors LLC increased its holdings in shares of Vivani Medical by 238.8% in the 1st quarter. Wealthedge Investment Advisors LLC now owns 125,033 shares of the company's stock valued at $131,000 after acquiring an additional 88,132 shares during the last quarter. Finally, Connective Capital Management LLC raised its position in shares of Vivani Medical by 796.2% during the 1st quarter. Connective Capital Management LLC now owns 162,098 shares of the company's stock worth $170,000 after acquiring an additional 144,010 shares in the last quarter. Institutional investors and hedge funds own 6.78% of the company's stock.
Vivani Medical Company Profile
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
